Ipsen announces the appointment of Sandra Silvestri as Executive Vice President, Medical Director, responsible for worldwide medical affairs and pharmacovigilance, effective May 5, succeeding Steven Hildemann who will leave the pharmaceutical group.

Sandra Silvestri will be a member of the executive leadership team and will report directly to CEO David Loew. She brings with her many years of medical experience in the global biopharmaceutical industry.

A physician specializing in endocrinology and metabolic diseases, she joins Ipsen from Sanofi, where she worked for eight years. Since 2020, she has held the position of senior vice president, chief medical officer of the global general medicine business unit.

Copyright (c) 2023 CercleFinance.com. All rights reserved.